Search for pathway correlated target
You are searching for: hsa04726
T53186 Target Info |
Target Name | Inward rectifier potassium channel Kir3.3 (KCNJ9) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | PIP2 | Drug Info |
T61227 Target Info |
Target Name | IP3 receptor isoform 1 (ITPR1) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | inositol 2,4,5-trisphosphate | Drug Info |
T99333 Target Info |
Target Name | Voltage-gated calcium channel alpha Cav1.4 (CACNA1F) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | L-(cis)-diltiazem | Drug Info |
T47966 Target Info |
Target Name | GN-binding protein G(I)/G(S)/G(O) gamma-7 (GNG7) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | Not Available |
T12290 Target Info |
Target Name | Guanine nucleotide-binding alpha-q (GNAQ) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | Not Available |
T76678 Target Info |
Target Name | IP3 receptor isoform 2 (IP3R2) | |
---|---|---|---|
Target type | Literature-reported Target | ||
Disease | Not Available | ||
Drugs | inositol 2,4,5-trisphosphate | Drug Info |
T00645 Target Info |
Target Name | HUMAN protein kinase cAMP-activated catalytic subunit alpha (PRKACA) | |
---|---|---|---|
Target type | . Target | ||
Disease | Not Available | ||
Drugs | Not Available |
T59480 Target Info |
Target Name | KRAS G12C mutant (KRAS G12C) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Non-small-cell lung cancer; Solid tumour/cancer; | ||
Drugs | Sotorasib | Drug Info |
T52489 Target Info |
Target Name | Rap guanine nucleotide exchange factor 3 (RAPGEF3) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Actinic keratosis; | ||
Drugs | AM001 | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.